Geron’s Imetelstat Headed To US FDA Advisory Committee For MDS

red blood cells
Around 50% Of MDS Patients Experience Thrombocytopenia • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers